Encoded Therapeutics Funding: $275M Round (Sep 2026)

Recent changes

Sep 9, 2026Sep 9, 2026Raised $275M Series F Encoded Therapeutics (Business Wire via BioSpace)
Sep 9, 2026Sep 9, 2026New investor: Google Ventures (GV) Encoded Therapeutics (Business Wire via BioSpace)
Sep 9, 2026Sep 9, 2026New investor: Janus Henderson Investors Encoded Therapeutics (Business Wire via BioSpace)
Sep 9, 2026Sep 9, 2026New investor: SoftBank Vision Fund Encoded Therapeutics (Business Wire via BioSpace)
Sep 9, 2026Sep 9, 2026New investor: ARCH Venture Partners Encoded Therapeutics (Business Wire via BioSpace)

Earlier changes (4)

Sep 9, 2026Sep 9, 2026New investor: Venrock Encoded Therapeutics (Business Wire via BioSpace)
Sep 9, 2026Sep 9, 2026New investor: RTW Investments Encoded Therapeutics (Business Wire via BioSpace)
Sep 9, 2026Sep 9, 2026New investor: Illumina Ventures Encoded Therapeutics (Business Wire via BioSpace)
Sep 9, 2026Sep 9, 2026New investor: Invus Encoded Therapeutics (Business Wire via BioSpace)

Funding History

1 event · sources dated per row

Date	Event	Amount	Valuation	Investors	Source
Sep 9, 2026	Series F	$275M	—	Google Ventures (GV)LeadARCH Venture PartnersIllumina VenturesInvusJanus Henderson InvestorsRTW InvestmentsSoftBank Vision FundVenrockBraidwellFarallon Capital ManagementMatrix Capital ManagementNolan Capital	Encoded Therapeutics (Business Wire via BioSpace)

Investors

Google Ventures (GV)ARCH Venture Partners Illumina Ventures Invus Janus Henderson Investors RTW Investments SoftBank Vision Fund Venrock

Latest Pulse

Sep 14, 2026Nine US Rounds, $8.7B, Ten Days: September's Real PaceValue Add Pulse totaled the nine largest US venture rounds of September 5-11 and found $8.7 billion committed, with three deals at $1 billion or more.→

No Value Add Pulse story covers Encoded Therapeutics yet. This profile is built from filings, registries and sourced research — every figure above carries its date and source.

Related Companies

Shared investors

Souffle Therapeutics

Same sector

Scribe Therapeutics Apnimed Attovia Therapeutics Retension Pharmaceuticals Braveheart Bio Eli Lilly

Encoded Therapeutics FAQ

Who are Encoded Therapeutics's investors?

Encoded Therapeutics's investors include Google Ventures (GV), ARCH Venture Partners, Illumina Ventures, Invus, Janus Henderson Investors, and 3 more.

Sources & methodologyshow

Where these figures come from

Encoded Therapeutics (Business Wire via BioSpace)research database1 fact

Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.

How we verify data · Suggest a correction